Skip to main content
TipRanks
Go Ultimate75% OFF

Aurinia Pharmaceuticals (IKAP) Q3 2021 Earnings Report

1 Followers

DE:IKAP Q3 2021 EPS Results

Actual EPS
-EUR 0.35
Consensus EPS
-EUR 0.30
Beat/Miss
Missed by -EUR 0.05
One Year Ago EPS
-EUR 0.25

DE:IKAP Q3 2021 Revenue Results

Actual Revenue
EUR 13.05M
Expected Revenue
EUR 12.34M
Beat/Miss
Beat by +EUR 709.92K
YoY Revenue Growth
+50475.86%

Earnings Announcement Details

Quarter
Q3 2021
Date
11/03/2021
Time
Before Open
Conference Call
Wednesday, November 3, 2021
DE:IKAP Upcoming Earnings

Aurinia Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q3 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:IKAP Earnings History

DE:IKAP earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)0.19-1.36――
Oct 30, 20262026 (Q3)0.200.200.20.00% (+0.00)
Aug 06, 20262026 (Q2)0.210.250.1475.00% (+0.11)
May 07, 20262026 (Q1)0.170.220.1456.25% (+0.08)
Feb 26, 20262025 (Q4)0.191.360.0115200.00% (+1.35)
Nov 04, 20252025 (Q3)0.140.200.09130.00% (+0.12)
Jul 31, 20252025 (Q2)0.130.140.011500.00% (+0.13)
May 12, 20252025 (Q1)0.090.14-0.06328.57% (+0.20)
Feb 27, 20252024 (Q4)-0.010.01-0.17105.26% (+0.18)
Nov 07, 20242024 (Q3)0.010.09-0.08211.11% (+0.17)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed